# Puma Venture Capital

Puma Venture Capital is a Venture Capital based in Del Mar, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Del Mar, United States
- **Region:** North America
- **Address:** Del Mar, CA, United States
- **Founded:** 2023
- **Assets under management:** Undisclosed
- **Website:** www.pumaventurecapital.com
- **LinkedIn:** https://www.linkedin.com/company/puma-venture-capital

## Regulatory record

- **CRD number:** 336542
- **SEC file number:** 802-134824
- **Registration status:** ACTIVE
- **Latest Form ADV filing:** 2026-04-06T05:00:00.000Z
- **Reports private funds:** Yes
- **Private funds reported:** 0
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/336542

## About

Puma Venture Capital invests in the robotics and AI ecosystem across all medical procedures to improve patient outcomes, boost labor productivity, and lower costs. The firm unifies medtech investment professionals with surgeon venture partners who are key opinion leaders. It focuses on robotic and autonomous systems, intelligence and embodied AI agents, intelligent infrastructure, procedural visualization and navigation, and next-gen instrumentation.

## Sectors

- AI/ML
- Robotics & Automation
- Healthcare Services

## People

- Amit Hazan — Co-Founder
- Dr. Vipul Patel — Co-Founder
- Dr. Fred Moll — Investment Team
- Scott Zinober — Investment Team

## Questions

### Who runs investment decisions at Puma Venture Capital?

Investment decisions are led by co-founder Amit Hazan, who has over 25 years of medical technology research and investing experience, including his most recent role as a Managing Director at Goldman Sachs. He is joined by Dr. Fred Moll, a pioneering surgical robotics entrepreneur and Intuitive Surgical co-founder, and Scott Zinober, former Senior Portfolio Manager for healthcare at Viking Global Investors. The firm also draws on the clinical judgment of co-founder Dr. Vipul Patel and the network of more than 20 surgeon venture partners.

### How does Puma Venture Capital source proprietary deal flow?

Deal flow is generated primarily through the firm's network of over 20 surgeon key opinion leaders, who practice across the most relevant surgical specialties and are embedded as venture partners. These clinicians provide early access to technologies under development, insight into clinical adoption challenges, and relationships across the robotics and AI ecosystems where founders often emerge. The investment team overlays this clinical sourcing with its private- and public-market investing lens to filter opportunities.

### Which sectors does Puma Venture Capital focus on?

The firm concentrates on the robotics and AI ecosystems across all medical procedures. Its investment areas include robotic and autonomous systems, intelligence and embodied AI agents, intelligent infrastructure, procedural visualization and navigation, and next-generation surgical instrumentation. The strategy spans platforms that improve patient outcomes, boost labor productivity, and reduce system-wide healthcare costs.

### How does Puma Venture Capital differ from other medtech venture firms?

Puma VC is built around a permanent network of more than 20 practicing surgeon venture partners—not part-time advisors—paired with a deal team whose backgrounds combine Wall Street medtech investing, hands-on robotics company building, and public-market portfolio management. This creates an institutionalized sourcing-and-diligence model where clinical insight is embedded directly into the investment process, giving the firm unusual access to early-stage technical and adoption signals.

## Related profiles

- [Puma Investments](https://altss.com/profile/puma-investments)
- [Punahou School](https://altss.com/profile/punahou-school)

---

Last updated: 2026-08-11T15:07:49.000Z

Canonical page: https://altss.com/profile/puma-venture-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology